FindTrial
Sign In

Short- term effect of sucroferric oxyhydroxide on phosphorus reduction in end -stage renal disease patients with hyperphosphatemia

Short- term effect of sucroferric oxyhydroxide on phosphorus reduction in end -stage renal disease patients with hyperphosphatemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098382
Enrollment
Unknown
Registered
2025-03-06
Start date
2024-11-05
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hyperphosphatemia in patients with end-stage renal disease

Interventions

Observation group:None

Sponsors

Ningbo First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >=18 years old; 2.peritoneal dialysis or hemodialysis; 3.phosphorus >=1.78mmo/L was detected before medication;

Exclusion criteria

Exclusion criteria: 1.Peritonitis occurred in the past 1 month; 2.Malignant diseases of gastrointestinal trac; 3.Combined use of other phosphorus reducing drugs;

Design outcomes

Primary

MeasureTime frame
venous phosphorus;—

Secondary

MeasureTime frame
potassium,calcium, magnesium and other electrolyte indicators;hemoglobin;Parathyroid hormone;—

Countries

China

Contacts

Public ContactAi Yuanyuan

Ningbo First Hospital

ayy130810@163.com+86 18867850437

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026